Back to results
US 2012/0251444 A1Published application
Treatment of liver disorders by administration of rap conjugates
AssigneeRaptor Pharmaceuticals Inc.
InventorsChristopher M. Starr, Todd C. Zankel
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of receptor-associate protein (RAP) and fragments and variants thereof to improve delivery of therapeutic compounds to the liver and provides methods to treat liver disorders and conditions, such as hepatic carcinoma, by administering RAP or RAP variants conjugated to active agents.
Claims31
A method of treating a liver disorder in a subject comprising:
- administering to said subject an effective amount of a conjugate comprising (a) a receptor binding moiety selected from the group consisting of Receptor Associated Protein of SEQ ID NO:
- 1 (RAP), RAP fragments, and RAP variants that retain RAP's binding affinity to LRP1 of about 1-5 nM, attached to (b) an active agent for treatment of liver disorder.
Dependencies are inferred from the claim text.